Home › Therapeutic areas › Metabolic › Long-Chain Fatty Acid Oxidation Disorders
Long-Chain Fatty Acid Oxidation Disorders (1 companies)
Companies with an active program in Long-Chain Fatty Acid Oxidation Disorders.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical | CardiovascularMetabolic+1 Rare | 1 | Approved | $1.57B | 10 |
No companies match.